Sorry, you need to enable JavaScript to visit this website.

NIMENRIX (Meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine) Dosage Forms, Composition And Packaging

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Dosage Forms, Composition And Packaging

Dosage Form

NIMENRIX (meningococcal polysaccharide groups A, C, W-135 and Y conjugate vaccine) is supplied as a sterile lyophilized white powder or cake in a single dose vial.

The diluent (sodium chloride and water for injections) is a sterile clear and colourless liquid supplied separately in a prefilled syringe or ampoule*.

*Format not available in Canada.

After reconstitution, NIMENRIX is a clear colourless solution.

Composition

After reconstitution, 1 dose (0.5 mL) contains:

Active Ingredients
Neisseria meningitidis serogroup A polysaccharide1 5 micrograms
Neisseria meningitidis serogroup C polysaccharide1 5 micrograms
Neisseria meningitidis serogroup W-135 polysaccharide1 5 micrograms
Neisseria meningitidis serogroup Y polysaccharide1 5 micrograms
1conjugated to tetanus toxoid carrier protein 44 micrograms

Excipients

Powder:

Sucrose 28 mg
Trometamol 97 mcg

Diluent:

Sodium chloride 4.5 mg
Water for Injections q.s. to 0.5 mL

Packaging

NIMENRIX is supplied in a 3 mL single dose glass vial. The diluent (0.5 mL) is supplied in a prefilled syringe or ampoule*.

The vials, syringes, and ampoules* are made of neutral glass Type 1.

NIMENRIX is available in pack sizes as follows:

  • Single dose vial packaged with pre-filled syringe of diluent with or without needles in pack sizes of 1 and 10.
  • Single dose vial packaged with ampoule* of diluent in pack sizes of 1, 10 or 100.

*Format not available in Canada.

 

Control #: 220188
December 19, 2018

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111